Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Harvard Business School

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076827

« Back to Dashboard

NDA 076827 describes VINORELBINE TARTRATE, which is a drug marketed by Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in ten NDAs. It is available from three suppliers. Additional details are available on the VINORELBINE TARTRATE profile page.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
Summary for 076827
Ingredient:vinorelbine tartrate
Formulation / Manufacturing:see details
Pharmacology for NDA: 076827
Ingredient-typeVinca Alkaloids
Suppliers and Packaging for NDA: 076827
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827 ANDA Hospira, Inc. 61703-341 N 61703-341-09

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Jun 2, 2005TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.